These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38361118)

  • 21. Overview of Neuromuscular Disorder Molecular Diagnostic Experience for the Population of Latvia.
    Lace B; Micule I; Kenina V; Setlere S; Strautmanis J; Kazaine I; Taurina G; Murmane D; Grinfelde I; Kornejeva L; Krumina Z; Sterna O; Radovica-Spalvina I; Vasiljeva I; Gailite L; Stavusis J; Livcane D; Kidere D; Malniece I; Inashkina I
    Neurol Genet; 2022 Jun; 8(3):e685. PubMed ID: 36381256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two Approaches for a Genetic Analysis of Pompe Disease: A Literature Review of Patients with Pompe Disease and Analysis Based on Genomic Data from the General Population.
    Park KS
    Children (Basel); 2021 Jul; 8(7):. PubMed ID: 34356580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimation of hereditary fructose intolerance prevalence in the Chinese population.
    Tang M; Chen X; Ni Q; Lu Y; Wu B; Wang H; Yin Z; Zhou W; Dong X
    Orphanet J Rare Dis; 2022 Aug; 17(1):326. PubMed ID: 36028839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lifetime risk of autosomal recessive mitochondrial disorders calculated from genetic databases.
    Tan J; Wagner M; Stenton SL; Strom TM; Wortmann SB; Prokisch H; Meitinger T; Oexle K; Klopstock T
    EBioMedicine; 2020 Apr; 54():102730. PubMed ID: 32305867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allele frequency analysis of variants reported to cause autosomal dominant inherited retinal diseases question the involvement of 19% of genes and 10% of reported pathogenic variants.
    Hanany M; Sharon D
    J Med Genet; 2019 Aug; 56(8):536-542. PubMed ID: 30910914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuromuscular disorders: finding the missing genetic diagnoses.
    Koczwara KE; Lake NJ; DeSimone AM; Lek M
    Trends Genet; 2022 Sep; 38(9):956-971. PubMed ID: 35908999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of genetic susceptibility for breast and ovarian cancer in a non-cancer related study population: secondary germline findings from a Swiss single centre cohort.
    Kraemer D; Azzarello-Burri S; Steindl K; Boonsawat P; Zweier M; Dedes KJ; Joset P; Fink D; Rauch A
    Swiss Med Wkly; 2019 Aug; 149():w20092. PubMed ID: 31422574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The global prevalence and genetic spectrum of lysosomal acid lipase deficiency: A rare condition that mimics NAFLD.
    Carter A; Brackley SM; Gao J; Mann JP
    J Hepatol; 2019 Jan; 70(1):142-150. PubMed ID: 30315827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carrier burden of over 300 diseases in Han Chinese identified by expanded carrier testing of 300 couples using assisted reproductive technology.
    Chen SC; Zhou XY; Li SY; Zhao MM; Huang HF; Jia J; Xu CM
    J Assist Reprod Genet; 2023 Sep; 40(9):2157-2173. PubMed ID: 37450097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carrier screening in the Mexican Jewish community using a pan-ethnic expanded carrier screening NGS panel.
    Morgenstern-Kaplan D; Raijman-Policar J; Majzner-Aronovich S; Aradhya S; Pineda-Alvarez DE; Aguinaga M; García-Vences EE
    Genet Med; 2022 Apr; 24(4):821-830. PubMed ID: 34961661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comprehensive genomic approach for neuromuscular diseases gives a high diagnostic yield.
    Ankala A; da Silva C; Gualandi F; Ferlini A; Bean LJ; Collins C; Tanner AK; Hegde MR
    Ann Neurol; 2015 Feb; 77(2):206-14. PubMed ID: 25380242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome sequencing with comprehensive variant calling identifies structural variants and repeat expansions in a large fraction of individuals with ataxia and/or neuromuscular disorders.
    Ek M; Nilsson D; Engvall M; Malmgren H; Thonberg H; Pettersson M; Anderlid BM; Hammarsjö A; Helgadottir HT; Arnardottir S; Naess K; Nennesmo I; Paucar M; Hjartarson HT; Press R; Solders G; Sejersen T; Lindstrand A; Kvarnung M
    Front Neurol; 2023; 14():1170005. PubMed ID: 37273706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carrier frequency of autosomal recessive genetic conditions in diverse populations: Lessons learned from the genome aggregation database.
    Schmitz MJ; Aarabi M; Bashar A; Rajkovic A; Gregg AR; Yatsenko SA
    Clin Genet; 2022 Aug; 102(2):87-97. PubMed ID: 35532184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex differences in neuromuscular disorders.
    Vinciguerra C; Iacono S; Bevilacqua L; Landolfi A; Piscosquito G; Ginanneschi F; Schirò G; Di Stefano V; Brighina F; Barone P; Balistreri CR
    Mech Ageing Dev; 2023 Apr; 211():111793. PubMed ID: 36806604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Respiratory muscle training in children and adults with neuromuscular disease.
    Silva IS; Pedrosa R; Azevedo IG; Forbes AM; Fregonezi GA; Dourado Junior ME; Lima SR; Ferreira GM
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011711. PubMed ID: 31487757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscular dystrophies and myopathies: the spectrum of mutated genes in the Czech Republic.
    Stehlíková K; Skálová D; Zídková J; Haberlová J; Voháňka S; Mazanec R; Mrázová L; Vondráček P; Ošlejšková H; Zámečník J; Honzík T; Zeman J; Magner M; Šišková D; Langová M; Gregor V; Godava M; Smolka V; Fajkusová L
    Clin Genet; 2017 Mar; 91(3):463-469. PubMed ID: 27447704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved diagnostic yield of neuromuscular disorders applying clinical exome sequencing in patients arising from a consanguineous population.
    Fattahi Z; Kalhor Z; Fadaee M; Vazehan R; Parsimehr E; Abolhassani A; Beheshtian M; Zamani G; Nafissi S; Nilipour Y; Akbari MR; Kahrizi K; Kariminejad A; Najmabadi H
    Clin Genet; 2017 Mar; 91(3):386-402. PubMed ID: 27234031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring the landscape of pathogenic genetic variation in the ExAC population database: insights of relevance to variant classification.
    Song W; Gardner SA; Hovhannisyan H; Natalizio A; Weymouth KS; Chen W; Thibodeau I; Bogdanova E; Letovsky S; Willis A; Nagan N
    Genet Med; 2016 Aug; 18(8):850-4. PubMed ID: 26681313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allele frequency of variants reported to cause adenine phosphoribosyltransferase deficiency.
    Runolfsdottir HL; Sayer JA; Indridason OS; Edvardsson VO; Jensson BO; Arnadottir GA; Gudjonsson SA; Fridriksdottir R; Katrinardottir H; Gudbjartsson D; Thorsteinsdottir U; Sulem P; Stefansson K; Palsson R
    Eur J Hum Genet; 2021 Jul; 29(7):1061-1070. PubMed ID: 33707627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenic variant-based preconception carrier screening in the Israeli Jewish population.
    Davidov B; Levon A; Volkov H; Orenstein N; Karo R; Fatal Gazit I; Magal N; Basel-Salmon L; Golan Mashiach M
    Clin Genet; 2022 May; 101(5-6):517-529. PubMed ID: 35315053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.